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SUMMARY – Chronic pain is a widespread healthcare problem with great impact on mental 
health, professional and family life of the patient. It can be a consequence of many disorders; howe-
ver, its pathogenesis has not yet been fully understood. Neuroplasticity is the ability of the nervous 
system to adapt to different changes and it is present throughout life, not only in prenatal period, 
infancy and childhood. However, in the pathophysiology of chronic pain, neuroplasticity shows 
its “dark side”. Due to the central sensitization process, noxious stimuli can produce chronic pain 
or misinterpretation of non-noxious stimuli (secondary hyperalgesia and allodynia). These changes 
occur at the level of brain cortex as well at peripheral nerves and receptors. This review summarizes 
a significant portion of literature dealing with neuroplasticity processes in well known chronic pain 
conditions such as migraine, chronic posttraumatic headache, low back pain, fibromyalgia, and ot-
hers. The relevance of this topic lies in providing a new insight in the pathophysiology of chronic 
pain, while also offering a possibility of new therapeutic approaches including not only pharmaco-
logical agents.  
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Introduction
Until a few decades ago, the neuroscientific dogma 
on the unchangeable human nervous system was com-
mon except for degenerative processes. The only peri-
ods believed to enable possible brain changes were the 
prenatal period, childhood and youth. It was consid-
ered that after this age, continuous neuron cell death 
occurs and atrophy of the mammal brain begins. In 
the years after The Decade of Brain, new discoveries 
emerged, one of them being neuroplasticity. Compre-
hensive researches have shown that nervous system is 
constantly changing due to new neuron connections 
which are developing in response to new stimulation 
or new environment1,2. Results of these studies have 
revealed that brain can adapt to compensate the dis-
ease and disability; it is possible to alter its structure 
and to generate new neurons3. That adult human brain 
is not definite and static, was also depicted by Eriks-
son et al. in their study showing that new neurons are 
generated continuously throughout life from neural 
stem cells in mammals in the area of dentate gyrus 
and in the zone next to the walls of lateral ventricles. 
Their results indicated human hippocampus to retain 
the ability to generate neurons throughout life4. This 
neurogenesis is believed to be one form of neuroplas-
ticity that enables adaptation of the body to environ-
mental changes.  
Pain is an unpleasant sensory and emotional experi-
ence associated with actual or potential tissue damage, 
or described in terms of such a damage5. Nociception 
implies the process of interaction of noxious stimulus 
with a receptor, transmission and processing pain re-
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lated signals in the peripheral and central nervous sys-
tem. Nociceptors are found in all body organs except 
for the brain and spinal cord. Neuropeptides released 
from nociceptors are producing sterile inflammation 
response that enhances nociception, which results in 
pain hypersensitivity (peripheral sensitization). Noci-
ceptive stimulus travels in peripheral nerves to poste-
rior horn of the spinal cord; at this level, central sensi-
tization processes may lower the nociceptor threshold 
and promote development of chronic pain.
Through spinothalamic tract and spinoreticular 
tract, impulses are ascending towards the brain where 
reticular formation regulates arousal reactions, auto-
nomic reflexes and emotional responses. Thalamus 
relays and differentiates nociceptive stimuli, while 
limbic system mediates emotional and motivation 
aspects of nociception. Somatosensory cortex has the 
function of pain differentiation and localization, and 
descending pathways modulate nociception6. Prosta-
glandins, glutamate, enkephalin, endorphin, GABA, 
serotonin/norepinephrine, substance P and histamine 
are neurotransmitters and neuropeptides with impor-
tant role in nociception and pharmacotherapy is tar-
geting these neurochemistry processes7. Pain can be 
of nociceptive type, it arises from actual or potential 
tissue damage and it is a result of the activation of 
nociceptors in an intact nervous system. It can be so-
matic and visceral. Neuropathic type of pain is caused 
by damage to nerve tissue. Initially, nociceptive pain 
can transform to neuropathic pain. Chronic pain can 
be taken as a disorder for itself, but not a single one. 
It is a consequence of many clinical disorders; it af-
fects a large proportion of population and poses a 
widespread healthcare problem with negative impact 
on mental health, professional and family life of the 
patient. Although studied at different levels, it is not 
yet completely understood and not enough specifi-
cally treated. Current medications (anticonvulsants 
and antidepressants) are not fully effective because 
they are not specific substances for chronic pain and 
another problem is the occurrence of often and sig-
nificant side effects. Chronic pain can be associated 
with serious progressive illness (malignancy, etc.), a 
consequence of static medical condition (amputation, 
herpes zoster), and often is of unknown etiology, i.e. 
a consequence of disturbance in neural functioning or 
complex combination of neural disturbances and psy-
chological disturbances (fibromyalgia, chronic pelvic 
pain of unknown etiology, chronic tension type head-
ache, etc.)8-10.  
Neuroplasticity and Pain
Neuroplasticity processes are involved in chronic 
pain development, but they can also be induced by 
medications used in the treatment of pain11. Neuro-
plastic changes can take place in the periphery, spinal 
cord and in brain centers after injury or inflammation; 
these changes lead to development of chronic pain 
syndromes. Central sensitization is one of neuroplastic 
changes; it is a widespread, persistent hyperexcitabil-
ity state of central neurons due to repetitive peripheral 
firing from afferent neurons. The most important con-
sequence of these neuroplastic changes in chronic pain 
is reduced filtering ability of central sensory neurons 
in the brain and spinal cord resulting in wrong inter-
pretation of noxious stimuli that can be exaggerated 
(secondary hyperalgesia) or misinterpreted; non-nox-
ious stimuli are perceived as painful ones (allodynia)12. 
If inflammation from injury is treated appropriately 
and the disease process is controlled, hypersensitivity 
usually resolves (modulation of primary and second-
ary neurons in the processes of peripheral and central 
sensitization is reversible). But if inflammation from 
injury persists, modification in central neurons occurs 
and involves even changes in the structure, connec-
tivity and survival of neurons; these changes lead to 
an increased activity of neurons in the central pain 
pathway with a fixed central sensitization and chronic 
pain13,14. Continuous and intense stimuli that lead to 
neuroplastic changes in the spinal cord and brain re-
sult in fixed central sensitization and chronic pain and 
there is growing evidence that these changes underlie 
the processes present in a number of pain conditions 
such as fibromyalgia, low back pain, migraine, tem-
poromandibular disorder and other headaches15-18. The 
sequels of neuroplasticity after peripheral nerve injury 
are disturbed sensation and chronic pain due to the loss 
of endogenous inhibition mechanisms, which leads to 
hypersensitivity and pain, as well as due to reorgani-
zation of the central nervous system19. Nerve injury is 
followed by the processes of re-innervation, collateral 
branching of undamaged neurons and remodeling of 
nervous system connections. However, the results of 
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these processes aimed to compensate for functional 
deficits can lead to maladaptive changes that lead to 
neuropathic pain20. The main mechanism is selective 
death of GABAergic neurons in dorsal horns of the 
spinal cord that occurs after injury consequently lead-
ing to the loss of the GABA mediated inhibition21. 
Peripheral nerve injury also leads to decreased ex-
pression of µ-opioid receptors in dorsal root ganglion 
neurons, which is associated with attenuation of the 
effects of opioids and other analgesics in neuropathic 
pain22. Chronic posttraumatic headache develops in 
up to 15% of patients with whiplash injury. A study 
performed in 33 patients with posttraumatic headache 
using magnetic resonance-based voxel-based mor-
phometry discovered neuroplastic, adaptive changes 
of the central nervous system. Results showed that 
patients with chronic headache revealed a decrease in 
gray matter in the anterior cingulate and dorsolateral 
prefrontal cortex after 3 months. These changes re-
solved after one year, in parallel to cessation of head-
ache and the same patients showed an increase of gray 
matter in antinociceptive brainstem centers, thalamus 
and cerebellum one year after the accident23. Reor-
ganization in primary somatosensory cortex associ-
ated with chronic pain was also revealed in patients 
with unilateral chronic pain after herpes simplex in-
fection without peripheral nerve injury24. Phantom 
limb pain is one of the best known consequences of 
brain plasticity. In this condition, after limb amputa-
tion, brain cortex reorganization in motor, but also in 
somatosensory areas starts. Similar changes can also 
occur at the level of spinal cord or thalamus. This cor-
tical reorganization can be stopped and reversed by 
exercises using mental imagery and thus the intensity 
of pain and exacerbations of pain can be reduced25,26. 
Fibromyalgia is a central sensitization syndrome. This 
chronic condition is characterized by musculoskeletal 
pains all over the body, but without muscle, bone and 
joint pathology. Disturbed interpretation of the sense 
of touch is present and touch is perceived as a painful 
stimulus. In this condition, depression, sleep, immune 
system, metabolism and endocrine disorders are also 
involved. All of these factors influence brain changes 
leading to fibromyalgia. Some studies revealed that 
the loss of gray matter occurs in fibromyalgia patients. 
Additional proof that fibromyalgia is a central sen-
sitization syndrome and not a local musculoskeletal 
condition is the success of centrally acting drugs in its 
treatment (pregabalin)27-29. Also chronic low back pain 
can induce reorganization of motor cortical areas30. A 
promising fact is that motor training can reverse re-
organization of neuronal circuits of motor cortex in 
people with recurrent low back pain, which can be 
used in nonpharmacological pain treatment31. 
Except as a response to noxious stimuli and dis-
ease, neuroplastic changes develop in response to 
medications. Repeated exposure to opioids leads to 
neuroplastic changes in spinal cord at the cellular and 
intracellular levels and is associated with activation 
of the NMDA receptors. The interaction of NMDA 
and opioid receptors can lead to irreversible degen-
erative neuroplastic changes in spinal cord that are 
connected to opioid tolerance. Similar changes oc-
cur after peripheral nerve injury. These findings may 
help understand the mechanism of opioid tolerance 
and difficulties in opioid treatment of neuropathic 
pain, which poses a major problem because most pain 
conditions are treated with opiates. In patients with 
migraine, plastic changes of neurotransmitter recep-
tors that are similar to changes in inflammatory pain 
states will probably develop during chronic morphine 
exposure. Calcitonin gene-related peptide levels in-
crease and peripheral and central sensitization de-
velops, with medication overuse headache as the end 
result32,33. Overuse of triptans can also induce neu-
roplastic changes in migraineurs, resulting in a state 
of latent sensitization, which might increase sensitiv-
ity to migraine triggers34. Some medication induced 
neuroplastic changes can also produce benefit in the 
treatment of pain conditions. One of the hypotheses 
is that psychoactive drugs that are often used in pain 
treatment may potentially influence adult neurogen-
esis and that this effect on neuroplasticity may con-
tribute to the therapeutic effect of antidepressants and 
antipsychotics. One of the theories proposed is that 
selective serotonin reuptake inhibitors (SSRI) increase 
neurogenesis in adult brain35,36.
Conclusion
This review summarizes a significant portion of 
the recent literature dealing with pain and connection 
with neuroplastic changes that develop as the result 
of chronic pain condition or as a causative element of 
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pain condition. As some studies have shown, medica-
tion can also induce neuroplastic changes. Based on 
this knowledge, the future aims in pharmacotherapy 
of chronic pain should be to develop a drug targeted 
to the mechanism of peripheral and central sensitiza-
tion and other neuroplastic mechanisms, thus to pro-
duce disease modifying agents. One of the hypoth-
eses is that a combination of opioid receptor agonists 
and NMDA receptor antagonists would be effective 
at this level. Taking into account that neuroplastic 
changes are induced by a repeated painful stimulus, 
which leads to central sensitization and chronic pain, 
guidelines for clinicians should clearly state that acute 
pain must be vigorously treated. 
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Sažetak 
MEHANIZMI NEUROPLASTIČNOSTI U PATOFIZIOLOGIJI KRONIČNE BOLI 
M. Bosnar Puretić i V. Demarin
Kronična bol je rašireni zdravstveni problem s velikim utjecajem na mentalno zdravlje, profesionalni i obiteljski život 
bolesnika. Ona može biti posljedica mnogih bolesti, ali njezina patogeneza još nije u potpunosti razjašnjena. Neuroplastič-
nost je sposobnost živčanog sustava da se prilagodi različitim promjenama i prisutna je tijekom cijeloga života, a ne samo 
u prenatalnom i dojenačkom razdoblju i djetinjstvu. Međutim, u patofiziologiji kronične boli neuroplastičnost pokazuje 
svoju „tamnu stranu“. Uslijed procesa središnje senzitizacije štetni podražaji uzrokuju kroničnu bol, a neštetni podražaji se 
tumače kao bolni (sekundarna hiperalgezija i alodinija). Ove promjene mogu se događati na razini moždane kore, ali i na 
razini perifernih živaca i receptora. Ovaj pregledni članak obuhvaća značajan dio literature u kojoj su prikazana istraživa-
nja koja su se bavila procesima neuroplastičnosti u čestim kroničnim bolnim stanjima poput migrene, kronične posttrau-
matske glavobolje, križobolje, fibromijalgije i drugima. Značenje ove tematike je u novom pristupu patofiziologiji kronične 
boli, odnosno u mogućnosti pronalaženja novih terapijskih opcija u liječenju kronične boli koje ne moraju sadržavati samo 
farmakološka sredstva. 
 Ključne riječi: Kronična bol; Neuroplastičnost; Središnja senzitizacija; Kortikalna reorganizacija 

